• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Blood Screening Market, Global Research Reports 2020-2021

report cover
  • 20 May 2020
  • Medical Devices
  • 99 Pages
  • Report Code: 24LS-2801
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Blood Screening Market Reports -MARKET ADVISORY SERVICES

This report covers market size and forecasts of Blood Screening, including the following market information:

  • Global Blood Screening Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Blood Screening Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Blood Screening Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Blood Screening Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)


Key market players
Major competitors identified in this market include Abbott Laboratories, Abbott, Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomrieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hem, etc.

Based on the Region:

  • Asia-Pacific (China, Japan, South Korea, India and ASEAN)
  • North America (US and Canada)
  • Europe (Germany, France, UK and Italy)
  • Rest of World (Latin America, Middle East & Africa)


Based on the Type:

  • Reagent
  • Instrument


Based on the Application:

  • Blood Bank
  • Hospital
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Blood Screening Industry
1.7 COVID-19 Impact: Blood Screening Market Trends

2 Global Blood Screening Quarterly Market Size Analysis
2.1 Blood Screening Business Impact Assessment - COVID-19
2.1.1 Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Blood Screening Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Blood Screening Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
3.1 Global Blood Screening Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Blood Screening Factory Price by Manufacturers
3.3 Location of Key Manufacturers Blood Screening Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Blood Screening Market
3.5 Key Manufacturers Blood Screening Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Blood Screening Segments, By Type
4.1 Introduction
1.4.1 Reagent
1.4.2 Instrument
4.2 By Type, Global Blood Screening Market Size, 2019-2021
4.2.1 By Type, Global Blood Screening Market Size by Type, 2020-2021
4.2.2 By Type, Global Blood Screening Price, 2020-2021

5 Impact of Covid-19 on Blood Screening Segments, By Application
5.1 Overview
5.5.1 Blood Bank
5.5.2 Hospital
5.2 By Application, Global Blood Screening Market Size, 2019-2021
5.2.1 By Application, Global Blood Screening Market Size by Application, 2019-2021
5.2.2 By Application, Global Blood Screening Price, 2020-2021

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa

7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Business Overview
7.1.2 Abbott Laboratories Blood Screening Quarterly Production and Revenue, 2020
7.1.3 Abbott Laboratories Blood Screening Product Introduction
7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott Blood Screening Quarterly Production and Revenue, 2020
7.2.3 Abbott Blood Screening Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Apex Biotechnology Corp.
7.3.1 Apex Biotechnology Corp. Business Overview
7.3.2 Apex Biotechnology Corp. Blood Screening Quarterly Production and Revenue, 2020
7.3.3 Apex Biotechnology Corp. Blood Screening Product Introduction
7.3.4 Apex Biotechnology Corp. Response to COVID-19 and Related Developments
7.4 Beckman Coulter (A Subsidiary of Danaher Corporation)
7.4.1 Beckman Coulter (A Subsidiary of Danaher Corporation) Business Overview
7.4.2 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Quarterly Production and Revenue, 2020
7.4.3 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Product Introduction
7.4.4 Beckman Coulter (A Subsidiary of Danaher Corporation) Response to COVID-19 and Related Developments
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Business Overview
7.5.2 Becton, Dickinson and Company Blood Screening Quarterly Production and Revenue, 2020
7.5.3 Becton, Dickinson and Company Blood Screening Product Introduction
7.5.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.6 Biomrieux
7.6.1 Biomrieux Business Overview
7.6.2 Biomrieux Blood Screening Quarterly Production and Revenue, 2020
7.6.3 Biomrieux Blood Screening Product Introduction
7.6.4 Biomrieux Response to COVID-19 and Related Developments
7.7 Bio-Rad Laboratories, Inc.
7.7.1 Bio-Rad Laboratories, Inc. Business Overview
7.7.2 Bio-Rad Laboratories, Inc. Blood Screening Quarterly Production and Revenue, 2020
7.7.3 Bio-Rad Laboratories, Inc. Blood Screening Product Introduction
7.7.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.8 F. Hoffmann-La Roche
7.8.1 F. Hoffmann-La Roche Business Overview
7.8.2 F. Hoffmann-La Roche Blood Screening Quarterly Production and Revenue, 2020
7.8.3 F. Hoffmann-La Roche Blood Screening Product Introduction
7.8.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
7.9 Grifols
7.9.1 Grifols Business Overview
7.9.2 Grifols Blood Screening Quarterly Production and Revenue, 2020
7.9.3 Grifols Blood Screening Product Introduction
7.9.4 Grifols Response to COVID-19 and Related Developments
7.10 Hem
7.10.1 Hem Business Overview
7.10.2 Hem Blood Screening Quarterly Production and Revenue, 2020
7.10.3 Hem Blood Screening Product Introduction
7.10.4 Hem Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis
8.1 Blood Screening Supply Chain Analysis
8.1.1 Blood Screening Supply Chain Analysis
8.1.2 Covid-19 Impact on Blood Screening Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Blood Screening Distribution Channels
8.2.2 Covid-19 Impact on Blood Screening Distribution Channels
8.2.3 Blood Screening Distributors
8.3 Blood Screening Customers

9 Key Findings

10 Appendix
10.1 About Us
10.2 Disclaimer
List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Blood Screening Assessment

Table 9. COVID-19 Impact: Blood Screening Market Trends

Table 10. COVID-19 Impact Global Blood Screening Market Size

Table 11. Global Blood Screening Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Blood Screening Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Blood Screening Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Blood Screening Market Growth Drivers

Table 17. Global Blood Screening Market Restraints

Table 18. Global Blood Screening Market Opportunities

Table 19. Global Blood Screening Market Challenges

Table 20. Key Manufacturers Blood Screening Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Blood Screening Market Size, 2019 (K Units) & (US$ Million)

Table 22. Blood Screening Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Blood Screening Manufacturing Plants

Table 24. Key Manufacturers Blood Screening Market Served

Table 25. Date of Key Manufacturers Enter into Blood Screening Market

Table 26. Key Manufacturers Blood Screening Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Blood Screening Market Size by Type, 2020, (US$ Million)

Table 29. Global Blood Screening Market Size by Type, 2020 (K Units)

Table 30. Global Blood Screening Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Blood Screening Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Blood Screening Market Size by Application, 2020-2021 (K Units)

Table 33. Global Blood Screening Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Blood Screening Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Blood Screening Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Blood Screening Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Blood Screening Market Size, 2019-2021 (K Units)

Table 38. US Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Blood Screening Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Blood Screening Market Size, 2019-2021 (K Units)

Table 43. Germany Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Blood Screening Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Blood Screening Market Size, 2019-2021 (K Units)

Table 50. China Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Abbott Laboratories Business Overview

Table 58. Abbott Laboratories Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Abbott Laboratories Blood Screening Product

Table 60. Abbott Laboratories Response to COVID-19 and Related Developments

Table 61. Abbott Business Overview

Table 62. Abbott Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Abbott Blood Screening Product

Table 64. Abbott Response to COVID-19 and Related Developments

Table 65. Apex Biotechnology Corp. Business Overview

Table 66. Apex Biotechnology Corp. Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Apex Biotechnology Corp. Blood Screening Product

Table 68. Apex Biotechnology Corp. Response to COVID-19 and Related Developments

Table 69. Beckman Coulter (A Subsidiary of Danaher Corporation) Business Overview

Table 70. Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Product

Table 72. Beckman Coulter (A Subsidiary of Danaher Corporation) Response to COVID-19 and Related Developments

Table 73. Becton, Dickinson and Company Business Overview

Table 74. Becton, Dickinson and Company Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Becton, Dickinson and Company Blood Screening Product

Table 76. Becton, Dickinson and Company Response to COVID-19 and Related Developments

Table 77. Biomrieux Business Overview

Table 78. Biomrieux Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Biomrieux Blood Screening Product

Table 80. Biomrieux Response to COVID-19 and Related Developments

Table 81. Bio-Rad Laboratories, Inc. Business Overview

Table 82. Bio-Rad Laboratories, Inc. Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Bio-Rad Laboratories, Inc. Blood Screening Product

Table 84. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments

Table 85. F. Hoffmann-La Roche Business Overview

Table 86. F. Hoffmann-La Roche Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. F. Hoffmann-La Roche Blood Screening Product

Table 88. F. Hoffmann-La Roche Response to COVID-19 and Related Developments

Table 89. Grifols Business Overview

Table 90. Grifols Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Grifols Blood Screening Product

Table 92. Grifols Response to COVID-19 and Related Developments

Table 93. Hem Business Overview

Table 94. Hem Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Hem Blood Screening Product

Table 96. Hem Response to COVID-19 and Related Developments

Table 97. Blood Screening Distributors List

Table 98. Blood Screening Customers List

Table 99. Covid-19 Impact on Blood Screening Customers

List of Figures

Figure 1. Blood Screening Product Picture

Figure 2. Blood Screening Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Blood Screening Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Blood Screening Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Blood Screening Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Blood Screening Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Blood Screening Market Size Market Share, 2019-2021

Abbott Laboratories

Abbott

Apex Biotechnology Corp.

Beckman Coulter (A Subsidiary of Danaher Corporation)

Becton, Dickinson and Company

Biomrieux

Bio-Rad Laboratories, Inc.

F. Hoffmann-La Roche

Grifols

Hem

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2633

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase